Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer

Ziyi Cheng, Namhyun Choi, Rui Wang, Sangyeop Lee, Kyung Chul Moon, Soo-Young Yoon, Lingxin Chen, Jaebum Choo

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Accurate analysis of specific biomarkers in clinical serum is essential for early diagnosis and treatment of cancer. Here, a surface-enhanced Raman scattering (SERS)-based immunoassay, using magnetic beads and SERS nano tags, was developed for the determination of free to total (f/t) prostate specific antigen (PSA) ratio to improve the diagnostic performance of prostate cancer. To assess the clinical applicability of the proposed method, SERS-based assays for the simultaneous detection of dual PSA markers, free PSA (f-PSA) and complexed PSA (c-PSA), were performed for clinical samples in the gray zone between 4.0 and 10.0 ng/mL. Our assay results for f/t PSA ratio showed a good linear correlation with those measured using the electrochemiluminescence (ECL) system installed in the clinical laboratory of the University Hospital. In addition, the simultaneous assay provided better precision than parallel assays for the detection of f-PSA and c-PSA in 13 clinical serum samples. Therefore, our SERS-based assay for simultaneous detection of dual PSA markers in clinical fluids has strong potential for application in the accurate diagnosis of prostate cancer.

Original languageEnglish
Pages (from-to)4926-4933
Number of pages8
JournalACS Nano
Volume11
Issue number5
DOIs
Publication statusPublished - 2017 May 23

Fingerprint

immunoassay
antigens
Prostate-Specific Antigen
Antigens
Raman scattering
cancer
Assays
Raman spectra
serums
markers
Clinical laboratories
biomarkers
Biomarkers
beads
Fluids
fluids

Keywords

  • free to total PSA ratio
  • multiplex detection
  • prostate cancer
  • SERS-based immunoassay
  • simultaneous detection

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer. / Cheng, Ziyi; Choi, Namhyun; Wang, Rui; Lee, Sangyeop; Moon, Kyung Chul; Yoon, Soo-Young; Chen, Lingxin; Choo, Jaebum.

In: ACS Nano, Vol. 11, No. 5, 23.05.2017, p. 4926-4933.

Research output: Contribution to journalArticle

Cheng, Ziyi ; Choi, Namhyun ; Wang, Rui ; Lee, Sangyeop ; Moon, Kyung Chul ; Yoon, Soo-Young ; Chen, Lingxin ; Choo, Jaebum. / Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer. In: ACS Nano. 2017 ; Vol. 11, No. 5. pp. 4926-4933.
@article{bbb37f768b8548cf9e4337371f6bc865,
title = "Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer",
abstract = "Accurate analysis of specific biomarkers in clinical serum is essential for early diagnosis and treatment of cancer. Here, a surface-enhanced Raman scattering (SERS)-based immunoassay, using magnetic beads and SERS nano tags, was developed for the determination of free to total (f/t) prostate specific antigen (PSA) ratio to improve the diagnostic performance of prostate cancer. To assess the clinical applicability of the proposed method, SERS-based assays for the simultaneous detection of dual PSA markers, free PSA (f-PSA) and complexed PSA (c-PSA), were performed for clinical samples in the gray zone between 4.0 and 10.0 ng/mL. Our assay results for f/t PSA ratio showed a good linear correlation with those measured using the electrochemiluminescence (ECL) system installed in the clinical laboratory of the University Hospital. In addition, the simultaneous assay provided better precision than parallel assays for the detection of f-PSA and c-PSA in 13 clinical serum samples. Therefore, our SERS-based assay for simultaneous detection of dual PSA markers in clinical fluids has strong potential for application in the accurate diagnosis of prostate cancer.",
keywords = "free to total PSA ratio, multiplex detection, prostate cancer, SERS-based immunoassay, simultaneous detection",
author = "Ziyi Cheng and Namhyun Choi and Rui Wang and Sangyeop Lee and Moon, {Kyung Chul} and Soo-Young Yoon and Lingxin Chen and Jaebum Choo",
year = "2017",
month = "5",
day = "23",
doi = "10.1021/acsnano.7b01536",
language = "English",
volume = "11",
pages = "4926--4933",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer

AU - Cheng, Ziyi

AU - Choi, Namhyun

AU - Wang, Rui

AU - Lee, Sangyeop

AU - Moon, Kyung Chul

AU - Yoon, Soo-Young

AU - Chen, Lingxin

AU - Choo, Jaebum

PY - 2017/5/23

Y1 - 2017/5/23

N2 - Accurate analysis of specific biomarkers in clinical serum is essential for early diagnosis and treatment of cancer. Here, a surface-enhanced Raman scattering (SERS)-based immunoassay, using magnetic beads and SERS nano tags, was developed for the determination of free to total (f/t) prostate specific antigen (PSA) ratio to improve the diagnostic performance of prostate cancer. To assess the clinical applicability of the proposed method, SERS-based assays for the simultaneous detection of dual PSA markers, free PSA (f-PSA) and complexed PSA (c-PSA), were performed for clinical samples in the gray zone between 4.0 and 10.0 ng/mL. Our assay results for f/t PSA ratio showed a good linear correlation with those measured using the electrochemiluminescence (ECL) system installed in the clinical laboratory of the University Hospital. In addition, the simultaneous assay provided better precision than parallel assays for the detection of f-PSA and c-PSA in 13 clinical serum samples. Therefore, our SERS-based assay for simultaneous detection of dual PSA markers in clinical fluids has strong potential for application in the accurate diagnosis of prostate cancer.

AB - Accurate analysis of specific biomarkers in clinical serum is essential for early diagnosis and treatment of cancer. Here, a surface-enhanced Raman scattering (SERS)-based immunoassay, using magnetic beads and SERS nano tags, was developed for the determination of free to total (f/t) prostate specific antigen (PSA) ratio to improve the diagnostic performance of prostate cancer. To assess the clinical applicability of the proposed method, SERS-based assays for the simultaneous detection of dual PSA markers, free PSA (f-PSA) and complexed PSA (c-PSA), were performed for clinical samples in the gray zone between 4.0 and 10.0 ng/mL. Our assay results for f/t PSA ratio showed a good linear correlation with those measured using the electrochemiluminescence (ECL) system installed in the clinical laboratory of the University Hospital. In addition, the simultaneous assay provided better precision than parallel assays for the detection of f-PSA and c-PSA in 13 clinical serum samples. Therefore, our SERS-based assay for simultaneous detection of dual PSA markers in clinical fluids has strong potential for application in the accurate diagnosis of prostate cancer.

KW - free to total PSA ratio

KW - multiplex detection

KW - prostate cancer

KW - SERS-based immunoassay

KW - simultaneous detection

UR - http://www.scopus.com/inward/record.url?scp=85019918661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019918661&partnerID=8YFLogxK

U2 - 10.1021/acsnano.7b01536

DO - 10.1021/acsnano.7b01536

M3 - Article

C2 - 28441008

AN - SCOPUS:85019918661

VL - 11

SP - 4926

EP - 4933

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 5

ER -